Clinical Trials Directory

Trials / Conditions / Fallopian Tube Carcinosarcoma

Fallopian Tube Carcinosarcoma

9 registered clinical trials studyying Fallopian Tube Carcinosarcoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingFolate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV O
NCT06639074
Mayo ClinicPhase 2
RecruitingVaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity
NCT05920798
Mayo ClinicPhase 1 / Phase 2
RecruitingAPL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment
NCT04919629
Roswell Park Cancer InstitutePhase 2
CompletedPamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer
NCT05494580
Sun Yat-sen UniversityPhase 1 / Phase 2
TerminatedOlaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal
NCT03924245
Vanderbilt-Ingram Cancer CenterPhase 1
TerminatedThe Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors
NCT03641287
University of WashingtonN/A
TerminatedMV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cance
NCT02364713
Mayo ClinicPhase 2
CompletedNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance
NCT02020707
Mayo ClinicPhase 1
CompletedCarboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovar
NCT00989651
National Cancer Institute (NCI)Phase 1